BROWNSTEIN HYATT FARBER SCHRECK, LLP

BROWNSTEIN HYATT FARBER SCHRECK, LLP filed a Q4 report for HARMONY BIOSCIENCES on January 16, 2026, reporting $50,000 in lobbying income.

Lobbying for HARMONY BIOSCIENCES · Biopharmaceutical company

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 16, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Lobbying activity 1

Issues related to the development and approval of therapies for rare diseases Pharmaceutical tarrifs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.